Frontlight ResearchEarly access
Trial site
InterKardioML s.r.o.
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- Atrial fibrillation1 trial
- Obesity1 trial
- Stroke1 trial
- Phase
- Phase 34 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim2 trials
- Anthos Therapeutics, Inc.1 trial
- AstraZeneca1 trial
- Novo Nordisk A/S1 trial
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure3 recruiting
- Obesity1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026